SCHEMBL9416258

SCHEMBL9416258

O=C(O)CSC(=S)c1ccc(F)cc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
BCL2L1 Q07817 1/20 0.42
BAD Q92934 1/20 0.42
PTPN1 P18031 1/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CXCR2 P25025 1/20 0.40
TSHR P16473 1/20 0.38
PAM P19021 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL162936 0.82 ALDH1A1 (0.52) NPC1RAB9AALDH1A1SMN1; SMN2CES2
SCHEMBL2108708 0.81 HDAC3 (0.49) LMNANPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL2705458 0.81 HDAC3 (0.51) LMNANPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL4832150 0.81 ALDH1A1 (0.50) NPC1RAB9AALDH1A1SMN1; SMN2CES2
SCHEMBL9416229 0.81 CES2 (0.48) CES2CES1PTPN1KMT2AMAPT
SCHEMBL10428977 0.79 PLK1 (0.44) LMNANPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL9416273 0.79 KMT2A (0.39) LMNANPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL9416248 0.77 RAB9A (0.47) LMNANPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL9416250 0.77 MAPT (0.67) ALDH1A1CES2CES1KMT2AMAPT
SCHEMBL10793580 0.77 MAPT (0.38) LMNAALDH1A1KMT2AMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014152453-A2 CONTINUOUS FLOW SYNTHESIS OF DITHIOESTER COMPOUNDS SIGMA-ALDRICH CO. LLC (US) 2014-09-25 WO disclosed
EP-0601520-A1 Trifluorothymidine derivatives, process for producing the same and anti-cancer agent containing the same MITSUI TOATSU CHEMICALS, Inc. (JP) 1994-06-15 EP disclosed
US-4000147-A ANTICONVULSANTS, CENTRAL NERVOUS SYSTEM DISORDERS BASF AKTIENGESELLSCHAFT (DT) 1976-12-28 US disclosed